CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 240 enrolled
Drug / intervention
OxyNorm Capsules +1 moredrug
Likely dose
OxyNorm Capsules 5mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01675635
NCT01675635Phase 3Completed

A Double-blind, Randomized, Parallel Group Study to Compare the Efficacy and Safety, of Oxycodone Immediate-release Capsules Versus Morphine Immediate-release Tablets in Hospitalized Patients With Moderate to Severe Pain Following Surgery.

Mundipharma (China) Pharmaceutical Co. Ltd·interventional·Posted Aug 30, 2012·Updated Feb 26, 2018

In Brief

A Phase 3 clinical trial evaluating OxyNorm Capsules and Morphine tablet for Postoperative Pain. Completed, enrolled 240 participants.

Detailed Summary

The efficacy and safety of oxycodone capsules compared with morphine tablets in hospitalized patients with moderate to severe pain following surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--

Timeline

Phase 3CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedAug 30, 2012
Enrollment StartJul 1, 2011
Primary CompletionJun 1, 2012
Study CompletionJul 1, 2012
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 13.8 years ago

Interventions

OxyNorm Capsulesdrug

dosage:5mg,l0mg and 20mg dosage form:capsule frequency:every 6h, duration:24 hours

Morphine tabletother

dosage: 10mg and 20mg; dosage form: tablet; frequency: every 6h; duration: 24 hours.